Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 296
Titolo Tipologia Data di pubblicazione Autori File
Exploring glioblastoma heterogeneity: the impact of ecDNA on tumor evolution and progression 02 - Intervento a convegno 2025 Ghizzi, MCazzaniga, GBentivegna, A +
HDAC7 induction combined with standard-of-care chemotherapy provides a therapeutic advantage in t(4;11) infant B-cell acute lymphoblastic leukemia 01 - Articolo su rivista 2025 Cazzaniga G. +
PAX5::AUTS2 childhood B-ALL: a relapse-prone genetic subtype with frequent central nervous system involvement and a poor outcome: ACUTE LYMPHOBLASTIC LEUKEMIA 01 - Articolo su rivista 2025 Fazio G.Cazzaniga G. +
Cohesins: Crossroad Between Cornelia de Lange Spectrum and Cancer Predisposition 01 - Articolo su rivista 2025 Rebellato S.Saitta C.Fazio G.Cazzaniga G. +
A novel RTEL1 nonsense variant in a case of familial pulmonary fibrosis: clinical description and genetic implications 01 - Articolo su rivista 2025 Franco, GiovanniAloisi, FilippoPromi, SamueleZanini, UmbertoFaverio, PaolaBentivegna, AngelaCazzaniga, GiovanniLuppi, Fabrizio +
Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation 01 - Articolo su rivista 2025 Lussana, FedericoMagnani, Chiara F.Galimberti, StefaniaGritti, GiuseppeBelotti, DanielaMoretti, AlexBuracchi, ChiaraRambaldi, BenedettaRizzuto, GiulianaPaganessi, MurielMeli, CristianTettamanti, SarahRisca, GiuliaSpinozzi, GiulioCazzaniga, GiovanniGotti, ElisaIntrona, MartinoBalduzzi, AdrianaValsecchi, Maria GraziaRambaldi, AlessandroBiondi, Andrea +
Overt and covert genetic causes of pediatric acute lymphoblastic leukemia: ACUTE LYMPHOBLASTIC LEUKEMIA 01 - Articolo su rivista 2025 Cazzaniga G. +
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia 01 - Articolo su rivista 2025 Saettini, FrancescoGuerra, FabiolaMauri, MarioChinello, CliziaDenti, VannaFazio, GraziaMalighetti, FedericaPagani, LisaQuadri, ManuelRebellato, StefanoSavino, Angela MariaMagni, FulvioPaglia, GiuseppeCazzaniga, GianniPiazza, RoccoBiondi, Andrea +
Minimal Residual Disease in Paediatric ALL: Significance and Methodological Approaches 03 - Contributo in libro 2024 Cazzaniga G. +
Clinical pilot study on microfluidic automation of IGH-VJ library preparation for next generation sequencing 01 - Articolo su rivista 2024 Rigamonti S.Cazzaniga G. +
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 01 - Articolo su rivista 2024 Crespiatico I.Mastini C.D'Aliberti D.Mauri M.Mercado C. M.Fontana D.Spinelli S.Crippa V.Inzoli E.Manghisi B.Civettini I.Ramazzotti D.Sangiorgio V.Brambilla V.Aroldi A.Barone C.Orsenigo R.Serafini M.Mottadelli F.Cazzaniga G.Pagni F.Azzoni E.Gambacorti Passerini C.Elli E. M.Mologni L.Piazza R. +
Four Additional Doses of PEG-L-Asparaginase during the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study 01 - Articolo su rivista 2024 Valsecchi M. G.Rizzari C.Cazzaniga G.Biondi A. +
NG2 is a target gene of MLL-AF4 and underlies glucocorticoid resistance in MLL-r B-ALL by regulating NR3C1 expression 01 - Articolo su rivista 2024 Bardini M.Cazzaniga G. +
Prenatal origin of NUTM1 gene rearrangement in infant B-cell precursor acute lymphoblastic leukaemia 01 - Articolo su rivista 2024 Bardini M.Fazio G.Sala S.Palamini S.Rebellato S.Rizzari C.Biondi A.Cazzaniga G. +
Analysis of measurable residual disease by IG/TR gene rearrangements: quality assurance and updated EuroMRD guidelines 01 - Articolo su rivista 2024 Cazzaniga G. +
The gray area of RQ-PCR-based measurable residual disease: subdividing the “positive, below quantitative range” category 01 - Articolo su rivista 2024 Cazzaniga G. +
Cytogenetically Balanced Reciprocal Translocation Could Hide Molecular Genomic Unbalances: Implications for Foetal Phenotype Correlation 01 - Articolo su rivista 2024 Villa N.Redaelli S.Farina S.Sala E.Crosti F.Cozzolino S.Verderio M.Roversi G.Bentivegna A.Cazzaniga G.Lavitrano M.Conconi D. +
Diverse mechanisms of leukemogenesis associated with PAX5 germline mutation 01 - Articolo su rivista 2024 Bettini L. R.Fazio G.Saitta C.Piazza R.Palamini S.Buracchi C.Rebellato S.Biondi A.Cazzaniga G. +
First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis Mimicking Triple Negative Myelofibrosis 02 - Intervento a convegno 2024 D. FontanaI. CrespiaticoC. MastiniD. D’AlibertiM. MauriCM. MercadoS. SpinelliV. CrippaE. InzoliB. ManghisiI. CivettiniD. RamazzottiV. SangiorgioM. GengottiV. BrambillaA. AroldiC. BaroneR. OrsenigoA. CorsiM. SerafiniG. CazzanigaF. PagniE. AzzoniA. SessaC. Gambacorti-PasseriniEM. ElliL. MologniRocco Piazza. +
Synergistic drug interactions of the histone deacetylase inhibitor givinostat (ITF2357) in CRLF2-rearranged pediatric B-cell precursor acute lymphoblastic leukemia identified by high-throughput drug screening 01 - Articolo su rivista 2024 Oikonomou A.Valsecchi L.Savino A. M.Bardini M.Fazio G.Biondi A.Cazzaniga G.Palmi C. +
Mostrati risultati da 1 a 20 di 296
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile